Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 30920 matches for

Published in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.

Image showing the projection of the single cell defined clusters into the tissue sections with labelling of some cells from different clusters using the antibodies against the markers that define those clusters

About us

Research groups

Trials

Available studentship projects

Applications for this project are now closed.

UCB-Translational Pharmacology Scholarship

Applications for this project are now closed.

Oxford Trauma

OPEN ARMS

Study with us

Events

SITU

Jobs

Trials in closure

Trials in follow up

Trials under analysis

Trials open to recruitment

Trials in set-up

Themes

OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.

Our studies

Lymphocyte Antigen Receptor Signaling Workshop

Information Security Policy

Load More

MEET THE TEAM

IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation

Read in Science Immunology

Find out more about

Similar stories